| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP And GC
1 company
Baity Glenn is an EVP And GC at ACADIA PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 20, 2016 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 10,000 | $30.00 | $300,001.00 | -12.3% | |
| Nov 10, 2016 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 10,200 | $30.07 | $306,687.48 | -13.9% | |
| Jul 12, 2016 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 16,000 | $35.00 | $560,032.77 | -11.3% | |
| Mar 2, 2016 | ACAD Acadia Pharmaceuticals Inc | EVP And GC | Sale+OE | 7,000 | $20.80 | $145,579.70 | -10.0% |